Imax (IMAX) EBITDA (2010 - 2026)

Imax has disclosed EBITDA across 17 years of filings, most recently posting $20.8 million for Q2 2026.

• In Q2 2026, EBITDA rose 44.81% year-over-year to $20.8 million; the TTM figure through Jun 2026 stood at $83.9 million (up 39.78% YoY), while the FY2025 annual figure was $84.2 million, up 92.03% from the prior year.
• EBITDA came in at $20.8 million for Q2 2026 at Imax, up from $10.0 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $29.0 million in Q3 2025 to a low of -$8.0 million in Q1 2022.
• Average EBITDA over 5 years is $11.4 million, with a median of $11.7 million recorded in 2023.
• Year-over-year, EBITDA tumbled 396.83% in 2022 and surged 14185.15% in 2023.
• Over 5 years, EBITDA stood at $7.5 million in 2022, then plunged by 63.66% to $2.7 million in 2023, then jumped by 247.28% to $9.5 million in 2024, then jumped by 153.41% to $24.1 million in 2025, then declined by 13.82% to $20.8 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $20.8 million in Q2 2026, $10.0 million in Q1 2026, and $24.1 million in Q4 2025.